LON/0TDF (LON/0TDF)

London Stock Exchange: LON/0TDF · USD

$59.9

-0.36 (-0.6%)· Recorded snapshot

Market cap	287.3B
Revenue (ttm)	58.7B
Net income (ttm)	11.5B
EPS (ttm)	$1.74
P/E (trailing)	25.9x
P/E (forward)	18.7x
Dividend	$0.73 (1.63%)
Volume	53
Beta	0.33

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 58.7B
Net income (ttm): 11.5B
EPS (ttm): $1.74
P/E (trailing): 25.9x
P/E (forward): 18.7x
Market cap: 287.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.7

P25 n/aP50 n/aP75 n/a

Trailing P/E25.9

P25 n/aP50 n/aP75 n/a

ROE38.1

P25 n/aP50 n/aP75 n/a

ROIC28.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LON/0TDF indicators

Market & fundamental data

Available fields

246

Groups with data

Currency

CHF

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	Switzerland
Country code	UK
Earnings date	2026-10-28
Employees	103,249
Employees change	-356
Employees growth	-0.34%
Enterprise value	$312.3B
Exchange	London Stock Exchange
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1896
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US7711951043
Last earnings date	2026-07-23
Last refreshed	2026-10-28
Market cap	$287.3B
Next earnings date	2026-10-28
Price	$59.88
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	lon/0TDF
Website	https://www.roche.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	20.44x
Average P/E ratio (3Y)	20.61x
Average P/E ratio (5Y)	20.31x
Earnings yield	3.86%
EV/Earnings	27.27x
EV/EBIT	16.63x
EV/EBITDA	14.3x
EV/FCF	21.37x
EV/Sales	5.5x
FCF / EV yield	4.68%
FCF yield	5.08%
Forward P/E	18.68x
Graham number	19.63858
Graham upside	-67.4%
Lynch fair value	$12.00
Lynch upside	-80.08%
P/(FCF - SBC) ratio	20.81x
P/(OCF - SBC) ratio	16.72x
P/B ratio	8.44x
P/E ratio	25.9x
P/FCF ratio	19.67x
P/OCF ratio	15.98x
P/S ratio	4.92x
Price / tangible book value	55.27x
Price/EBITDA ratio	12.92x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.12%
EBITDA margin	38.06%
Effective tax rate	18.74%
FCF margin	25.76%
Gross margin	74.17%
Operating margin	33.12%
Pretax margin	25.98%
Profit margin	19.6%
Profit per employee	$111,494
Profitable quarters	47
Profitable years	23
Revenue per employee	$568,799
ROA	13.51%
ROA (5Y)	13.31%
ROCE	30.06%
ROE	38.11%
ROE (5Y)	38.06%
ROIC	28.1%
ROIC (5Y)	32.56%
SBC / revenue	1.38%
Tax / revenue	4.87%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	30.57%
EPS growth (Q)	-7.69%
EPS growth (QoQ)	25.11%
EPS growth 10Y	3.82%
EPS growth 3Y	3.87%
EPS growth 5Y	-1.14%
EPS growth years	1
FCF growth	-0.29%
FCF growth (Q)	11.9%
FCF growth (QoQ)	-37.37%
FCF growth 3Y	6.53%
FCF growth 5Y	-0.37%
Gross profit growth	-1.65%
Gross profit growth (Q)	-2.07%
Gross profit growth 3Y	0.36%
Gross profit growth 5Y	0.78%
Net income growth	30.88%
Net income growth (Q)	-7.27%
Net income growth (QoQ)	25.61%
Net income growth 3Y	3.82%
Net income growth 5Y	-2.52%
Net income growth years	1
OCF growth	0.56%
OCF growth (Q)	7.54%
OCF growth (QoQ)	-35.03%
OCF growth 10Y	3.05%
OCF growth 3Y	5.46%
OCF growth 5Y	-0.34%
Operating income growth	2.89%
Operating income growth (Q)	-0.94%
Operating income growth 3Y	3.16%
Operating income growth 5Y	1.78%
Revenue growth	-0.83%
Revenue growth (Q)	-1.25%
Revenue growth (QoQ)	-0.17%
Revenue growth 10Y	2.01%
Revenue growth 3Y	0.23%
Revenue growth 5Y	0.28%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-3.4B
Depreciation and amortization	$2.8B
EBIT	$19.4B
EBITDA	$22.4B
EPS	$1.74
Financing cash flow	$-12.5B
Free cash flow	$14.7B
Free cash flow minus SBC	$13.9B
Gross profit	$43.6B
Income taxes	$2.9B
Investing cash flow	$-7.4B
Net borrowing	$-1.8B
Net cash flow	$-2B
Net income	$11.5B
Operating cash flow minus SBC	$17.3B
Operating income	$19.4B
Revenue	$58.7B
Stock-based compensation	$807.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.48
Book value per share	$38.27
Debt / EBITDA	1.37
Debt / equity	0.91
Debt / FCF	2.11
Goodwill	$7B
Interest coverage	18.24
Long-term assets	$59.5B
Long-term liabilities	$31.2B
Net cash (debt)	$-22B
Net cash / market cap	-7.61%
Net debt / EBITDA	0.98
Net debt / equity	0.64
Net debt / FCF	1.5
Piotroski F-Score	5
Property, plant and equipment	$21.2B
Shareholders' equity	$34.2B
Tangible book value	$5.2B
Tangible book value per share	$6.56
Total assets	$91.6B
Total cash	$9.1B
Total debt	$31.1B
Total liabilities	$57.4B
WACC	5.73%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.65
Current assets	$32.1B
Current liabilities	$26.1B
Current ratio	1.23
Inventory turnover	2.07
Net working capital	$3.2B
Quick ratio	0.8
Working capital	$6.1B
Working capital turnover	7.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.31%
Dividend growth	11.38%
Dividend growth (3Y)	6.64%
Dividend growth (5Y)	4.68%
Dividend growth years	6
Dividend payment date	2026-04-22
Dividend payment years	10
Dividend payout frequency	Annual
Dividend per share	$0.73
Dividend yield	1.63%
Ex-dividend date	2026-03-13
Last dividend	$0.97
Payout ratio	63.22%
Shareholder yield	1.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$53.07
1D price change	-0.6%
1M price change	10.05%
1M total return	10.05%
1W price change	1.3%
1W total return	1.3%
1Y price change	44.39%
1Y return CAGR	47.17%
1Y total return	47.13%
20-day SMA	$56.20
200-day SMA	$53.64
3M price change	8.54%
3M total return	8.54%
3Y price change	82.39%
3Y return CAGR	24.83%
3Y total return	94.56%
50-day SMA	$55.48
50-day SMA vs 200-day SMA	50over200
52-week high	$61.20
52-week high date	2026-10-23
52-week low	$40.40
52-week low date	2025-10-31
5Y price change	24.23%
5Y return CAGR	6.62%
5Y total return	37.78%
6M price change	16.93%
6M total return	16.93%
All-time high	$61.20
All-time high date	2026-10-23
All-time low	$27.60
All-time low date	2018-06-29
Average true range (ATR)	$1.04
Average volume	3K
Beta (5Y)	0.33
Change from 52-week high	-2.16%
Change from 52-week low	48.22%
Change from all-time high	-2.16%
Change from all-time low	116.96%
Change from open	0.86%
Day's gap	-1.44%
Dollar volume	$3,174
High price	$60.20
Low price	$59.37
Monthly RSI	66.1
Open price	$59.37
Position in 52-week range	61.45%
Previous close	$60.24
Price vs 150-day SMA	12.84%
Price vs 20-day SMA	6.54%
Price vs 200-day SMA	11.64%
Price vs 50-day SMA	7.92%
Relative volume	0.02
RSI	70.76
Sharpe ratio	1.48
Sharpe ratio (3Y)	0.49
Sortino ratio	2.69
Sortino ratio (3Y)	0.83
Volume	53
Weekly RSI	62.9
YTD price change	15.53%
YTD total return	17.72%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	723.7M
Shares change (QoQ)	0.5%
Shares change (YoY)	0.31%
Shares held by insiders	9.17%
Shares held by institutions	28.89%

Deeper analysis on LON/0TDF

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LON/0TDF report

Is a complete LON/0TDF research report available?

No complete published report is available for lon/0TDF (LON/0TDF) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0TDF (LON/0TDF)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0TDF

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0TDF indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0TDF

Frequently asked questions